At the news
? NEUTRALIMPACT 1/10 PRESS-RELEASE filed Jun 2, 2026 at 16:01 ET
Praxis Precision Medicines granted 2,754 restricted stock units to 13 new non-executive employees under its 2024 Inducement Plan, a routine equity inducement for new hires. The grant is immaterial in size relative to the company's $9.3B market cap and has no impact on operations or financials.
- Granted 2,754 RSUs to 13 new non-executive employees under the 2024 Inducement Plan
- Awards vest in four equal annual installments subject to continued employment
- Inducement grants are routine and comply with Nasdaq Listing Rule 5635(c)(4)
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access